Knight Therapeutics | GUD - Operating Profit

Stock Price
5.91
Daily Change
0.02 0.34%
Monthly
0.85%
Yearly
3.14%
Q1 Forecast
5.66

Knight Therapeutics reported CAD3.2M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
Acasti Pharma USD -2.53M 560K Sep/2025
Alaunos Therapeutics USD -1.19M 432K Sep/2025
Aurora Cannabis CAD -55.67M 35.45M Sep/2025
Avita Medical AUD -11.15M 1.19M Jun/2025
Canopy Growth CAD -14.3M 3.18M Sep/2025
Cronos Group USD 55.24M 59.63M Sep/2025
Dianthus Therapeutics USD -40.29M 5.36M Sep/2025
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
Knight Therapeutics CAD 3.2M 1.29M Sep/2024
Moderna USD -260M 647M Sep/2025
Organigram Holdings CAD -28.05M 7.76M Sep/2025
Organon & Co USD 388M 62M Sep/2025
Revvity USD 98.34M 8.63M Sep/2025
Tectonic Therapeutic USD -21.89M 440K Sep/2025
Tilray USD -20.01M 9.34M Sep/2025
Viatris USD 234.5M 49.1M Sep/2025
Xeris Pharmaceuticals USD 6.73M 2.25M Sep/2025